These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

566 related items for PubMed ID: 21711959

  • 21. Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.
    Lu S, Malice MP, Dass SB, Reiss TF.
    J Asthma; 2009 Nov; 46(9):878-83. PubMed ID: 19905912
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: effects on nasal congestion.
    Prenner B, Anolik R, Danzig M, Yao R.
    Allergy Asthma Proc; 2009 Nov; 30(3):263-9. PubMed ID: 19549427
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Desloratadine treatment for intermittent and persistent allergic rhinitis: a review.
    Bachert C, van Cauwenberge P.
    Clin Ther; 2007 Sep; 29(9):1795-802. PubMed ID: 18035184
    [Abstract] [Full Text] [Related]

  • 28. A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic Rhinitis.
    Kim MK, Lee SY, Park HS, Yoon HJ, Kim SH, Cho YJ, Yoo KH, Lee SK, Kim HK, Park JW, Park HW, Chung JH, Choi BW, Lee BJ, Chang YS, Jo EJ, Lee SY, Cho YS, Jee YK, Lee JM, Jung J, Park CS.
    Clin Ther; 2018 Jul; 40(7):1096-1107.e1. PubMed ID: 29945738
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
    Pleskow W, Grubbe R, Weiss S, Lutsky B.
    Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
    [Abstract] [Full Text] [Related]

  • 30. Montelukast in the treatment of allergic rhinitis: an evidence-based review.
    Nayak A, Langdon RB.
    Drugs; 2007 Mar; 67(6):887-901. PubMed ID: 17428106
    [Abstract] [Full Text] [Related]

  • 31. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
    Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, Reiss TF.
    J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172
    [Abstract] [Full Text] [Related]

  • 32. Quality of life in patients with persistent allergic rhinitis treated with desloratadine monotherapy or desloratadine plus montelucast combination.
    Erdoğan BA, Sanlı A, Paksoy M, Altın G, Aydın S.
    Kulak Burun Bogaz Ihtis Derg; 2014 May; 24(4):217-24. PubMed ID: 25046070
    [Abstract] [Full Text] [Related]

  • 33. Wheal and flare reactions in skin prick tests of patients treated with montelukast alone or in combination with antihistamines.
    Ciebiada MG, Barylski M, Ciebiada M.
    Inflamm Res; 2014 Mar; 63(3):191-5. PubMed ID: 24281730
    [Abstract] [Full Text] [Related]

  • 34. Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast.
    Phan H, Moeller ML, Nahata MC.
    Drugs; 2009 Mar; 69(18):2541-76. PubMed ID: 19943707
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of montelukast for treating perennial allergic rhinitis.
    Philip G, Williams-Herman D, Patel P, Weinstein SF, Alon A, Gilles L, Tozzi CA, Dass SB, Reiss TF.
    Allergy Asthma Proc; 2007 Mar; 28(3):296-304. PubMed ID: 17619558
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Efficacy of desloratadine in persistent allergic rhinitis - a GA²LEN study.
    Bousquet J, Bachert C, Canonica GW, Mullol J, Van Cauwenberge P, Jensen CB, Fokkens WJ, Ring J, Keith P, Gopalan G, Lorber R, Zuberbier T, ACCEPT-2 Study Group.
    Int Arch Allergy Immunol; 2010 Mar; 153(4):395-402. PubMed ID: 20559006
    [Abstract] [Full Text] [Related]

  • 40. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis.
    Hung CH, Hua YM, Hsu WT, Lai YS, Yang KD, Jong YJ, Chu YT.
    Pediatr Int; 2007 Jun; 49(3):322-7. PubMed ID: 17532829
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.